HeartSciences Adds European Unitary Patent Covering 19 Countries for AI-ECG Diastolic Assessment
HSCS•HeartSciences secures European Patent No. EP4252651, now holding over 45 patents, covering machine-learning models that estimate diastolic function parameters from ECG and demographics. The Unitary Patent, effective April 29, covers 19 EU countries and strengthens the company's AI-ECG intellectual property portfolio for enhanced commercial advantage.
1. Patent Grant Details
HeartSciences received European Patent No. EP4252651 for ECG-based diastolic function assessment using machine-learning models trained on ECG and echocardiography data, enabling quantitative estimation of echo parameters from ECG readings.
2. European Coverage and Portfolio Expansion
The Unitary Patent, effective April 29, 2026, provides protection in 19 EU countries, increasing HeartSciences’ granted patent count to more than 45 and reinforcing its global IP footprint.
3. Strategic and Commercial Impact
This patent strengthens HeartSciences’ AI-ECG intellectual property portfolio, supporting its strategy to transform ECG devices into front-line cardiac screening tools and offering a competitive edge as AI-ECG adoption expands.
